This commentary from Bioanalysis focuses on the status of drug detection with metal nanoparticles as ultrasmall labels in colorimetric-based methods.
Browsing: Drug Discovery and Development
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
Mike Brown (Q-Squared Solutions; GA, USA), discusses the different tests required when looking at a potential therapeutic and what aspects of biology need to be considered. He also explores how important early engagement with the FDA and clinical trial partners are.
Complete our short survey on proteomics and be the first to receive our informative infographic collated from the survey results.
Find out more about the latest news and developments in labs-on-chips in the investigation of gut inflammation and cellular responses in drug discovery in this round-up.
Find out what Naidong Weng (Janssen Research and Development) has to say about the future of bioanalytical outsourcing, in this expert interview.
Find out what Marco Michi (Aptuit) has to say about the future of bioanalytical outsourcing, in this expert interview.
Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum
In this manuscript, the European Bioanalysis Forum presents additional practice guidance on the use of flow cytometry in the support of drug development programs and addresses areas that are not covered in the previous publications.
Find out more about a novel biosensor for the real time oxygen monitoring for organ-on-a-chip systems, and a liquid biopsy for predicting lymphoma therapy success.
Find out more about the technologies involved in drug metabolism and what the future may hold for drug metabolism studies in drug discovery research in this ‘In the Zone’ feature.